BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30365984)

  • 1. Diagnostic yield and miss rate of EndoRings in an organized colorectal cancer screening program: the SMART (Study Methodology for ADR-Related Technology) trial.
    Hassan C; Senore C; Manes G; Fuccio L; Iacopini F; Ricciardiello L; Anderloni A; Frazzoni L; Ballanti R; de Nucci G; Colussi D; Redaelli D; Lorenzetti R; Devani M; Arena I; Grossi C; Andrei F; Balestrazzi E; Sharma P; Rex DK; Repici A
    Gastrointest Endosc; 2019 Mar; 89(3):583-590.e1. PubMed ID: 30365984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter, randomized, tandem evaluation of EndoRings colonoscopy--results of the CLEVER study.
    Dik VK; Gralnek IM; Segol O; Suissa A; Belderbos TD; Moons LM; Segev M; Domanov S; Rex DK; Siersema PD
    Endoscopy; 2015 Dec; 47(12):1151-8. PubMed ID: 26220283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full-spectrum (FUSE) versus standard forward-viewing colonoscopy in an organised colorectal cancer screening programme.
    Hassan C; Senore C; Radaelli F; De Pretis G; Sassatelli R; Arrigoni A; Manes G; Amato A; Anderloni A; Armelao F; Mondardini A; Spada C; Omazzi B; Cavina M; Miori G; Campanale C; Sereni G; Segnan N; Repici A
    Gut; 2017 Nov; 66(11):1949-1955. PubMed ID: 27507903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoma detection rates in colonoscopies for positive fecal immunochemical tests versus direct screening colonoscopies.
    Wong JCT; Chiu HM; Kim HS; Byeon JS; Matsuda T; Kobayashi N; Wu DC; Ong DE; Sung JJY;
    Gastrointest Endosc; 2019 Mar; 89(3):607-613.e1. PubMed ID: 30452915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-EYE colonoscopy is superior to standard colonoscopy for increasing adenoma detection rate: an international randomized controlled trial (with videos).
    Shirin H; Shpak B; Epshtein J; Karstensen JG; Hoffman A; de Ridder R; Testoni PA; Ishaq S; Reddy DN; Gross SA; Neumann H; Goetz M; Abramowich D; Moshkowitz M; Mizrahi M; Vilmann P; Rey JW; Sanduleanu-Dascalescu S; Viale E; Chaudhari H; Pochapin MB; Yair M; Shnell M; Yaari S; Hendel JW; Teubner D; Bogie RMM; Notaristefano C; Simantov R; Gluck N; Israeli E; Stigaard T; Matalon S; Vilkin A; Benson A; Sloth S; Maliar A; Waizbard A; Jacob H; Thielsen P; Shachar E; Rochberger S; Hershcovici T; Plougmann JI; Braverman M; Tsvang E; Abedi AA; Brachman Y; Siersema PD; Kiesslich R
    Gastrointest Endosc; 2019 Mar; 89(3):545-553. PubMed ID: 30273591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the yield and miss rate of narrow band imaging and white light endoscopy in patients undergoing screening or surveillance colonoscopy: a meta-analysis.
    Pasha SF; Leighton JA; Das A; Harrison ME; Gurudu SR; Ramirez FC; Fleischer DE; Sharma VK
    Am J Gastroenterol; 2012 Mar; 107(3):363-70; quiz 371. PubMed ID: 22186978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missed adenomas with behind-folds visualizing colonoscopy technologies compared with standard colonoscopy: a pooled analysis of 3 randomized back-to-back tandem colonoscopy studies.
    Brand EC; Dik VK; van Oijen MGH; Siersema PD
    Gastrointest Endosc; 2017 Aug; 86(2):376-385.e2. PubMed ID: 28069476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining Benchmarks for Adenoma Detection Rate and Adenomas Per Colonoscopy in Patients Undergoing Colonoscopy Due to a Positive Fecal Immunochemical Test.
    Hilsden RJ; Bridges R; Dube C; McGregor SE; Naugler C; Rose SM; Rostom A; Heitman SJ
    Am J Gastroenterol; 2016 Dec; 111(12):1743-1749. PubMed ID: 27725649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoma detection by Endocuff-assisted versus standard colonoscopy in an organized screening program: the "ItaVision" randomized controlled trial.
    Zorzi M; Hassan C; Battagello J; Antonelli G; Pantalena M; Bulighin G; Alicante S; Meggiato T; Rosa-Rizzotto E; Iacopini F; Luigiano C; Monica F; Arrigoni A; Germanà B; Valiante F; Mallardi B; Senore C; Grazzini G; Mantellini P;
    Endoscopy; 2022 Feb; 54(2):138-147. PubMed ID: 33524994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoma detection with Endocuff colonoscopy versus conventional colonoscopy: a multicentre randomised controlled trial.
    van Doorn SC; van der Vlugt M; Depla A; Wientjes CA; Mallant-Hent RC; Siersema PD; Tytgat K; Tuynman H; Kuiken SD; Houben G; Stokkers P; Moons L; Bossuyt P; Fockens P; Mundt MW; Dekker E
    Gut; 2017 Mar; 66(3):438-445. PubMed ID: 26674360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a ring-fitted cap on insertion time and adenoma detection: a randomized controlled trial.
    Rex DK; Kessler WR; Sagi SV; Rogers NA; Fischer M; Bohm ME; Wo JM; Dewitt JM; McHenry L; Lahr RE; Searight MP; MacPhail M; Sullivan AW; McWhinney CD; Vemulapalli KC
    Gastrointest Endosc; 2020 Jan; 91(1):115-120. PubMed ID: 31299257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Real-Time Computer-Aided Detection of Colorectal Neoplasia in a Randomized Trial.
    Repici A; Badalamenti M; Maselli R; Correale L; Radaelli F; Rondonotti E; Ferrara E; Spadaccini M; Alkandari A; Fugazza A; Anderloni A; Galtieri PA; Pellegatta G; Carrara S; Di Leo M; Craviotto V; Lamonaca L; Lorenzetti R; Andrealli A; Antonelli G; Wallace M; Sharma P; Rosch T; Hassan C
    Gastroenterology; 2020 Aug; 159(2):512-520.e7. PubMed ID: 32371116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing adenoma and polyp miss rates for total underwater colonoscopy versus standard CO
    Anderson JC; Kahi CJ; Sullivan A; MacPhail M; Garcia J; Rex DK
    Gastrointest Endosc; 2019 Mar; 89(3):591-598. PubMed ID: 30367879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoma Detection Rate in Asymptomatic Patients with Positive Fecal Immunochemical Tests.
    Kligman E; Li W; Eckert GJ; Kahi C
    Dig Dis Sci; 2018 May; 63(5):1167-1172. PubMed ID: 29468377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrograde inspection
    Rath T; Pfeifer L; Neufert C; Kremer A; Leppkes M; Hoffman A; Neurath MF; Zopf S
    World J Gastroenterol; 2020 Apr; 26(16):1962-1970. PubMed ID: 32390706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Endocuff use on colonoscopy outcomes: A systematic review and meta-analysis.
    Triantafyllou K; Gkolfakis P; Tziatzios G; Papanikolaou IS; Fuccio L; Hassan C
    World J Gastroenterol; 2019 Mar; 25(9):1158-1170. PubMed ID: 30863002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linked-color imaging versus white-light colonoscopy in an organized colorectal cancer screening program.
    Paggi S; Radaelli F; Senore C; Maselli R; Amato A; Andrisani G; Di Matteo F; Cecinato P; Grillo S; Sereni G; Sassatelli R; Manfredi G; Alicante S; Buscarini E; Canova D; Milan L; Pallini P; Iwatate M; Rondonotti E; Repici A; Hassan C
    Gastrointest Endosc; 2020 Sep; 92(3):723-730. PubMed ID: 32502550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis indicates that add-on devices and new endoscopes reduce colonoscopy adenoma miss rate.
    Gkolfakis P; Tziatzios G; Facciorusso A; Muscatiello N; Triantafyllou K
    Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1482-1490. PubMed ID: 30188409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program.
    Chiu SY; Chuang SL; Chen SL; Yen AM; Fann JC; Chang DC; Lee YC; Wu MS; Chou CK; Hsu WF; Chiou ST; Chiu HM
    Gut; 2017 Feb; 66(2):293-300. PubMed ID: 26515543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.